Zinc in PDB 3eob: Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II

The structure of Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II, PDB code: 3eob was solved by S.Li, J.Ding, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	50.00 / 3.60
Space group	P 61 2 2
Cell size a, b, c (Å), α, β, γ (°)	111.096, 111.096, 470.726, 90.00, 90.00, 120.00
R / Rfree (%)	26.7 / 33.3

The binding sites of Zinc atom in the Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II (pdb code 3eob). This binding sites where shown within 5.0 Angstroms radius around Zinc atom.
In total 2 binding sites of Zinc where determined in the Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II, PDB code: 3eob:
Jump to Zinc binding site number: 1; 2;

Zinc binding site 1 out of 2 in the Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 1 of Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II within 5.0Å range: probe atom residue distance (Å) B Occ I:Zn1 b:99.5 occ:1.00 OD1 I:ASP239 2.5 90.8 1.0 OG I:SER141 2.5 0.0 1.0 OG I:SER139 3.0 67.2 1.0 OD2 I:ASP239 3.1 90.8 1.0 CG I:ASP239 3.1 90.8 1.0 CB I:SER141 3.1 0.0 1.0 CB I:SER139 3.4 67.2 1.0 OD2 I:ASP137 3.7 92.7 1.0 OG1 I:THR206 3.7 77.2 1.0 N I:GLY240 4.0 99.2 1.0 CA I:GLY240 4.1 99.2 1.0 N I:SER141 4.2 89.8 1.0 C I:ASP239 4.3 84.7 1.0 CA I:SER141 4.3 89.8 1.0 CB I:ASP239 4.5 90.8 1.0 CG I:ASP137 4.6 92.7 1.0 OD1 I:ASP137 4.6 92.7 1.0 O I:ASP239 4.6 84.7 1.0 C I:SER141 4.8 89.8 1.0 CA I:SER139 4.8 90.1 1.0 CB I:THR206 4.9 77.2 1.0 CA I:ASP239 4.9 84.7 1.0 CG2 I:THR206 4.9 77.2 1.0 N I:ASP239 4.9 84.7 1.0 ND1 I:HIS264 5.0 0.6 1.0

Zinc binding site 2 out of 2 in the Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II


Mono view


Stereo pair view

A full contact list of Zinc with other atoms in the Zn binding site number 2 of Crystal Structure the Fab Fragment of Efalizumab in Complex with Lfa-1 I Domain, Form II within 5.0Å range: probe atom residue distance (Å) B Occ J:Zn2 b:99.5 occ:1.00 OD1 J:ASP239 2.3 0.6 1.0 OG J:SER139 2.8 93.4 1.0 OG J:SER141 2.8 82.2 1.0 CG J:ASP239 2.8 0.6 1.0 OD2 J:ASP239 2.9 0.6 1.0 CB J:SER139 3.3 93.4 1.0 OD2 J:ASP137 3.4 0.9 1.0 CB J:SER141 3.4 82.2 1.0 OG1 J:THR206 3.8 76.4 1.0 CD2 J:LEU142 3.8 76.4 1.0 O J:ASP239 4.0 81.3 1.0 C J:ASP239 4.0 81.3 1.0 N J:GLY240 4.2 80.5 1.0 CB J:ASP239 4.3 0.6 1.0 CG J:ASP137 4.3 0.9 1.0 OD1 J:ASP137 4.3 0.9 1.0 N J:SER141 4.4 77.0 1.0 CA J:GLY240 4.4 80.5 1.0 CA J:SER141 4.5 77.0 1.0 CA J:ASP239 4.6 81.3 1.0 N J:ASP239 4.7 81.3 1.0 CA J:SER139 4.7 77.5 1.0 N J:LEU142 4.8 72.6 1.0

S.Li, H.Wang, B.Peng, M.Zhang, D.Zhang, S.Hou, Y.Guo, J.Ding. Efalizumab Binding to the Lfa-1 Alphal I Domain Blocks Icam-1 Binding Via Steric Hindrance. Proc.Natl.Acad.Sci.Usa V. 106 4349 2009.
ISSN: ISSN 0027-8424
PubMed: 19258452
DOI: 10.1073/PNAS.0810844106